ALS (motor neurone disease) trials in Slovenia
1 of 2 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleEfficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
- Where
- Ljubljana
- Age
- 18 years to 81 years
- People
- 495 worldwide
- Run by
- AB Science
See details and how to joinNCT03127267